PSMD14 and cancer: The latest data have indicated that the reduced form of THL is an inhibitor of JAB1/MPN/Mov34 (JAMM) domain-containing metalloprotease RPN11 by chelating Zn2+-ions, which are specifically toxic to cancer cells by hampering protein turnover and inducing ubiquitylation [163].